News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
219 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (18629)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (243)
2 (71)
4 (13)
5 (208)
6 (219)
7 (196)
8 (217)
9 (66)
11 (10)
12 (147)
13 (179)
14 (161)
15 (149)
16 (59)
18 (5)
19 (123)
20 (157)
21 (145)
22 (146)
23 (65)
24 (1)
25 (5)
26 (148)
27 (167)
28 (180)
29 (149)
30 (99)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Expedeon AG signs commercial agreement with Sona Nanotech
Agreement will address limitations in development of multiplex point-of-care Lateral Flow Assay diagnostic tests
August 6, 2019
·
6 min read
Five Ways to Increase Your Competitive Edge in the Job Market
The five tips below are simple, yet extremely powerful in giving you a below-the-radar edge over the competition.
August 6, 2019
·
5 min read
·
Dana Farber, Sr. Career Branding Professional, SHRM-SCP, CPRW
Drug Development
Basilea Pharma’s Antibiotic Shows Non-inferiority in Late-Stage Trial
Basilea Pharmaceutica, based in Basel, Switzerland, announced positive topline data from its Phase III TARGET study of deftobiprole for acute bacterial skin and skin structure infections.
August 6, 2019
·
3 min read
·
Mark Terry
Business
NIH Researcher Launches LUCA Biologics, a Company Dedicated to Microbiome Diseases and Women’s Health
At this time, LUCA’s pipeline includes therapies for UTI, preterm birth and bacterial vaginosis.
August 6, 2019
·
2 min read
·
Mark Terry
Business
insitro Strengthens Executive Leadership Team with Key Appointments
insitro, a machine-learning driven drug discovery and development company, today announced two key leadership appointments.
August 6, 2019
·
5 min read
BioMidwest
LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development
Researchers can identify therapeutic targets and functional effects of targeted therapeutics more quickly and efficiently as part of a complete solution now offered by LI-COR Biosciences in partnership with NMI TT Pharmaservices.
August 6, 2019
·
3 min read
2020 Mitsui Chemicals Catalysis Science Awards
Mitsui Chemicals Inc. announced that Mitsui Chemicals Catalysis Science Awards will begin accepting applications for the “2020 Mitsui Chemicals Catalysis Science Awards” on September 2nd via web site of the company.
August 6, 2019
·
2 min read
Genetown
LUCA Biologics Launches to Develop Live Biotherapeutics for Women’s Health Starting with Urinary Tract Infection (UTI)
Emerging from 15 years of Dr. Jacques Ravel’s vaginal microbiome research, LUCA’s pipeline targets UTI, bacterial vaginosis (BV), and preterm birth (PTB)
August 6, 2019
·
4 min read
Drug Development
Astellas Initiates Phase 3 Clinical Trials for Fezolinetant in Postmenopausal Women with Vasomotor Symptoms
Astellas Pharma Inc. announced dosing of the first patient in the SKYLIGHT 1™ Phase 3 pivotal trial for fezolinetant, an investigational oral, non-hormonal compound being studied for the treatment of moderate-to-severe vasomotor symptoms – i.e., hot flashes and night sweats associated with menopause.
August 6, 2019
·
4 min read
Business
‘MYM International Brands Inc.’ Incorporated to Focus on Burgeoning Global Demand for CBD-Rich Consumer Products
The passing of the Farm Bill in 2018 allowed for the cultivation of CBD-rich hemp in the United States.
August 6, 2019
·
4 min read
Previous
2 of 22
Next